| Issue | Title | |
| Vol 1, Issue 2 (2021) | Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia | Abstract PDF (Eng) |
| M. A. Novitsky, A. De Sousa, A. R. Asadullin, O. A. Gavrilyuk, A. V. Petrov, R. F. Nasyrova | ||
| Vol 4, Issue 4 (2024) | Possibilities of Analyzing the Speech of Patients with Mental Disorders Using Mathematical Methods and Artificial Intelligence Algorithms | Abstract PDF (Eng) |
| M. A. Barulina, N. V. Zakharova, R. F. Nasyrova, D. M. Ivashinenko, M. A. Dvoryankina, A. I. Rakhmatullin | ||
| Vol 5, Issue 2 (2025) | Prediction of Congenital Malformations in The Fetus Based on The Carriage of Single Nucleotide Variants of Folate Cycle Genes by a Mother with Epilepsy | Abstract PDF (Eng) |
| Albina V. Yakunina, Anastasiya S. Chesnokova, Natalia N. Savelieva | ||
| Vol 4, Issue 1 (2024) | Predictive Pharmacogenetic Testing in Psychiatry: Pros and Cons | Abstract PDF (Eng) |
| A. Yu. Avilov, A. V. Kidyaeva, E. E. Vaiman | ||
| Vol 1, Issue 2 (2021) | Prevalence of non-motor disorders in Parkinson`s disease | Abstract PDF (Eng) |
| N. Yu. Safonova, M. R. Sapronova, O A. Gavrilyuk, T. E. Popova, A. A. Tappakhov | ||
| Vol 1, Issue 2 (2021) | Prospects for studying the pharmacokinetics, pharmacodynamics and pharmacogenetics of vitamin C in patients with neurological diseases and mental disorders | Abstract PDF (Eng) |
| P. S. Goncharova, T. K. Davydova, N. G. Zhukova | ||
| Vol 1, Issue 1 (2021) | Relations of CYP2C19*2 genetic polymorphisms to plasma and saliva concentrations of diazepam in patients hospitalized for alcohol withdrawal | Abstract PDF (Eng) |
| V. Yu. Skryabin, M. S. Zastrozhin, E. A. Grishina, K. A. Ryzhikova, V. V. Shipitsyn, T. E. Galaktionova, E. A. Bryun, D. A. Sychev | ||
| Vol 5, Issue 2 (2025) | Relationship Between Cognitive Functions and Oxytocin Levels in Patients with Multivessel Coronary Artery Disease | Abstract PDF (Eng) |
| Olga V. Mikhailova, Marina M. Petrova, Olga L. Lopatina | ||
| Vol 3, Issue 2 (2023) | Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders | Abstract PDF (Eng) |
| N. A. Shnayder, A. V. Kidyaeva, E. E. Vaiman, A. R. Asadullin, M. M. Petrova, D. S. Kaskaeva, G. V. Matyushin, A. A. Evsyukov, E. V. Galko, N. P. Garganeeva, G. A. Chumakova, N. V. Lareva, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 5, Issue 1 (2025) | Single-Nucleotide Variant rs167771 of the DRD3 Gene Does Not Increase the Risk of Developing Antipsychotic-Induced Parkinsonism in Schizophrenic Patients | Abstract PDF (Eng) |
| R. F. Nasyrova, N. A. Shnayder, I. R. Boiko, M. M. Petrova, G. A. Shipullin, G. A. Chumakova, N. P. Garganeeva | ||
| 81 - 90 of 105 Items | << < 4 5 6 7 8 9 10 11 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Alzheimer's disease
Parkinson's disease
adverse reaction
antiepileptic drugs
antipsychotic
antipsychotics
anxiety
biomarkers
candidate genes
epilepsy
genes
genetics
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
treatment
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
